PreprintCC BYmedRxiv
PrEgabalin for Treatment Resistant generalised Anxiety disorder: statistical analysis plan for a randomised controlled trial
- 1University College London
Abstract
This document describes the Statistical Analysis Plan (SAP) for PETRA, a randomised controlled trial in people with generalised anxiety disorder comparing pregabalin plus an antidepressant and standard care, with placebo plus an antidepressant and standard care, with respect to the primary outcome of the GAD-7 score at week 12.
Related
- Dietary Enhancement for Iron Deficiency and Anaemia Treatment (DEFeAT): study protocol for a randomised controlled trial to assess the effect of a mineral-enriched powder on iron deficiency in women of reproductive age
- Optimised blended treatment for alcohol use disorder (OptiBlend) in Dutch outpatient addiction care: study protocol for a three-arm randomised controlled trial
- Efficacy of ferrous fumarate with elemental iron 60 mg alternate-day, 120 mg alternate-day vs 60 mg once a day therapy in the treatment of iron deficiency anaemia: study protocol for a randomised controlled trial
- Adalimumab versus placebo as add-on to standard therapy for non-infectious uveitis in the United Kingdom: the ASTUTE randomised controlled trial with treatment run-in
- Nurse-Led treatment strategy based on asthma score and oxygen requirement in children with acute reversible bronchoconstriction: A randomised controlled non-inferiority trial
BibTeX
@misc{lewis2026pregabalin,
title = {{PrEgabalin for Treatment Resistant generalised Anxiety disorder: statistical analysis plan for a randomised controlled trial}},
author = {G. Lewis and N. Freemantle and H.-M. Dehbi and C. Clarke and E. Bordea},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.01.26359217},
url = {https://www.medrxiv.org/content/10.64898/2026.09.01.26359217v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - PrEgabalin for Treatment Resistant generalised Anxiety disorder: statistical analysis plan for a randomised controlled trial
AU - G. Lewis
AU - N. Freemantle
AU - H.-M. Dehbi
AU - C. Clarke
AU - E. Bordea
PY - 2026
DA - 2026/09/01
PB - medRxiv
DO - 10.64898/2026.09.01.26359217
UR - https://www.medrxiv.org/content/10.64898/2026.09.01.26359217v1
AB - This document describes the Statistical Analysis Plan (SAP) for PETRA, a randomised controlled trial in people with generalised anxiety disorder comparing pregabalin plus an antidepressant and standard care, with placebo plus an antidepressant and standard care, with respect to the primary outcome of the GAD-7 score at week 12.
ER -